Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÖzkay, Yusuf
dc.contributor.authorIşıkdağ, İlhan
dc.contributor.authorSeller, Zerrin
dc.contributor.authorAkalın Çiftçi, Gülsen
dc.date.accessioned2019-10-19T14:44:43Z
dc.date.available2019-10-19T14:44:43Z
dc.date.issued2010
dc.identifier.issn0223-5234
dc.identifier.urihttps://dx.doi.org/10.1016/j.ejmech.2010.04.015
dc.identifier.urihttps://hdl.handle.net/11421/13596
dc.descriptionWOS: 000279521800008en_US
dc.descriptionPubMed ID: 20451307en_US
dc.description.abstractIn the present study 18 novel imidazole-(benz)azole and imidazole-piperazine derivatives were synthesized in order to investigate their probable anticancer activity. The structures of the compounds were confirmed by IR, (1)H NMR and EI-MS spectral data. Cytotoxicity (MTT), analysis of DNA synthesis and detection of apoptotic DNA assays were applied to determine anticancer activity of the compounds against colon (HT-29) and breast (MCF-7) carcinoma cell lines. Most of the compounds, showed greater activity against HT-29 cells than MCF-7 cells. Some of them indicated considerable cytotoxicity against both of the carcinogenic cell lines. However, their inhibitory activity on DNA synthesis was relatively poor. Anticancer activity screening results revealed that 11, 12 and 13 were the most active compounds in the series. They exhibited significant cytotoxicity against both of the carcinogenic cell lines and caused DNA fragmentation of the HT-29 cellsen_US
dc.description.sponsorshipAnadolu University Scientific Research Projects Commission [070324]en_US
dc.description.sponsorshipThis work was financially supported by Anadolu University Scientific Research Projects Commission. Project number: 070324.en_US
dc.language.isoengen_US
dc.publisherElsevier France-Editions Scientifiques Medicales Elsevieren_US
dc.relation.isversionof10.1016/j.ejmech.2010.04.015en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCanceren_US
dc.subjectImidazoleen_US
dc.subjectAzole, Benzazoleen_US
dc.subjectPiperazineen_US
dc.subjectHt-29en_US
dc.subjectMcf-7en_US
dc.titleSynthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl) phenyl]acetamide derivatives and evaluation of their anticancer activityen_US
dc.typearticleen_US
dc.relation.journalEuropean Journal of Medicinal Chemistryen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalıen_US
dc.identifier.volume45en_US
dc.identifier.issue8en_US
dc.identifier.startpage3320en_US
dc.identifier.endpage3328en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorÖzkay, Yusuf
dc.contributor.institutionauthorSeller, Zerrin
dc.contributor.institutionauthorAkalın Çiftçi, Gülsen


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster